Biotech Values

[DewDiligence]

ALNY extends IPO lockup period by… 8 days!?

[I’ve never seen this kind of announcement.]

http://biz.yahoo.com/e/041104/alny8-k.html

>>
On November 3, 2004, Alnylam Pharmaceuticals, Inc. ("Alnylam") agreed with Banc of America Securities LLC, Citigroup Global Markets Inc., Piper Jaffray & Co., and ThinkEquity Partners LLC (collectively, the "Underwriters") to extend Alnylam's 180-day lockup agreement set forth in Section 3(k) of the Underwriting Agreement dated May 27, 2004 among Alnylam and the Underwriters by an additional 8 days. The lockup period will now run through and including December 1, 2004.

Additionally, each officer, director, stockholder and holder of an option to purchase common stock of Alnylam who previously executed a lockup agreement with the Underwriters has also agreed to an extension of his, her or its lockup through and including December 1, 2004.

The lockup periods have been extended in order to permit research analysts, in accordance with the rules of the National Association of Securities Dealers, Inc., to publish or distribute research reports and make public appearances concerning Alnylam at or about the time of the announcement of Alnylam's third quarter financial results on November 10, 2004.
<<